| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.53 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |